A Feasibility Study of AlzLife 40 Hz Sensory Therapy in Patients with MCI and Early AD

A Feasibility Study of AlzLife 40 Hz Sensory Therapy in Patients with MCI and Early AD

Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI) are debilitating diseases that affect millions of individuals and have notoriously limited treatment options. One emerging therapy, non-invasive 40 Hz sensory therapy delivered through light and sound has previously shown promise in improv...

Full description

Bibliographic Details
Main Authors: Sienna D. McNett, Andrey Vyshedskiy, Andrei Savchenko, Danijel Durakovic, George Heredia, Rael Cahn, Mikhail Kogan
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Healthcare
Subjects:
Alzheimer’s Disease
Mild Cognitive Impairment
light therapy
integrative medicine
technology
smart device
Online Access:https://www.mdpi.com/2227-9032/11/14/2040

Internet

https://www.mdpi.com/2227-9032/11/14/2040

Similar Items